This study aims to improve how doctors count and identify different types of cells and proteins in your eye if you have anterior uveitis. Anterior uveitis is a condition where the front part of your eye becomes inflamed, often due to other health issues. Researchers will use a special high-resolution imaging device called optical coherence tomography (OCT) to see if it can provide a clear, standard way to measure these cells. This is an observational study, meaning you won't receive a new treatment. Instead, researchers will gather information from your existing care. The study is looking for 125 participants between 5 and 85 years old who have active inflammation from various types of uveitis, including those linked to conditions like juvenile idiopathic arthritis (JIA) or herpes simplex virus (HSV). The main goal is to identify and measure these cells on the first day of the study.

Study design

This is an observational study with a planned enrollment of 125 participants. It is not a randomized trial and does not specify a phase.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

The primary endpoint, identification and measurement of anterior chamber cells, is measured at Day 1.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.